FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054895688> ?p ?o ?g. }

• W2054895688 endingPage "45" @default.
• W2054895688 startingPage "37" @default.
• W2054895688 abstract "This report evaluates prognostic and technical factors affecting outcome of patients with primary carcinoma of the vagina treated with definitive radiation therapy.A retrospective analysis was performed on records of 212 patients with histologically confirmed carcinoma of the vagina treated with irradiation.Tumor stage was the most significant prognostic factor; actuarial 10-year disease-free survival was 94% for Stage 0 (20 patients), 80% for Stage I (59 patients), 55% for Stage IIA (63 patients), 35% for Stage IIB (34 patients), 38% for Stage III (20 patients), and 0% for Stage IV (15 patients). All in situ lesions except one were controlled with intracavitary therapy. Of the patients with Stage I disease, 86% showed no evidence of vaginal or pelvic recurrence; most of them received interstitial or intracavitary therapy or both, and the addition of external-beam irradiation did not significantly increase survival or tumor control. In Stage IIA (paravaginal extension) and IIB (parametrial involvement) 66% and 56% of the tumors, respectively, were controlled with a combination of brachytherapy and external-beam irradiation; 13 of 20 (65%) Stage III tumors were controlled in the pelvis. Four patients with Stage IV disease (27%) had no recurrence in the pelvis. The total incidence of distant metastases was 13% in Stage I, 30% in Stage IIA, 52% in Stage IIB, 50% in Stage III, and 47% in Stage IV. The dose of irradiation delivered to the primary tumor or the parametrial extension was of relative importance in achieving successful results. In patients with Stage I disease, brachytherapy alone achieved the same local tumor control (80-100%) as in patients receiving external pelvic irradiation (78-100%) as well. In Stage II and III there was a trend toward better tumor control (57-80%) with combined external irradiation and brachytherapy than with the latter alone (33-50%) (p = 0.42). The incidence of grade 2-3 complications (12%) correlated with the stage of the tumor and type of treatment given.Radiation therapy is an effective treatment for patients with vaginal carcinoma, particularly Stage I. More effective irradiation techniques, including optimization of dose distribution combining external irradiation and interstitial brachytherapy in tumors beyond Stage I, are necessary to enhance locoregional tumor control. The high incidence of distant metastases emphasizes the need for earlier diagnosis and effective systemic cytotoxic agents to improve survival in these patients." @default.
• W2054895688 created "2016-06-24" @default.
• W2054895688 creator A5015505251 @default.
• W2054895688 creator A5026263532 @default.
• W2054895688 creator A5060036184 @default.
• W2054895688 creator A5076087889 @default.
• W2054895688 creator A5077796440 @default.
• W2054895688 date "1999-04-01" @default.
• W2054895688 modified "2023-09-27" @default.
• W2054895688 title "Factors affecting long-term outcome of irradiation in carcinoma of the vagina" @default.
• W2054895688 cites W1975073142 @default.
• W2054895688 cites W1977985094 @default.
• W2054895688 cites W1981240920 @default.
• W2054895688 cites W1984302332 @default.
• W2054895688 cites W1997612130 @default.
• W2054895688 cites W1997799304 @default.
• W2054895688 cites W2003821312 @default.
• W2054895688 cites W2010134948 @default.
• W2054895688 cites W2010326552 @default.
• W2054895688 cites W2029845172 @default.
• W2054895688 cites W2031632972 @default.
• W2054895688 cites W2043273668 @default.
• W2054895688 cites W2043951575 @default.
• W2054895688 cites W2047370015 @default.
• W2054895688 cites W2053450200 @default.
• W2054895688 cites W2062625202 @default.
• W2054895688 cites W2071167154 @default.
• W2054895688 cites W2072307434 @default.
• W2054895688 cites W2072670584 @default.
• W2054895688 cites W2091780426 @default.
• W2054895688 cites W2106147539 @default.
• W2054895688 cites W2137267683 @default.
• W2054895688 cites W2335001127 @default.
• W2054895688 doi "https://doi.org/10.1016/s0360-3016(98)00530-6" @default.
• W2054895688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10219792" @default.
• W2054895688 hasPublicationYear "1999" @default.
• W2054895688 type Work @default.
• W2054895688 sameAs 2054895688 @default.
• W2054895688 citedByCount "121" @default.
• W2054895688 countsByYear W20548956882012 @default.
• W2054895688 countsByYear W20548956882013 @default.
• W2054895688 countsByYear W20548956882014 @default.
• W2054895688 countsByYear W20548956882015 @default.
• W2054895688 countsByYear W20548956882016 @default.
• W2054895688 countsByYear W20548956882017 @default.
• W2054895688 countsByYear W20548956882018 @default.
• W2054895688 countsByYear W20548956882019 @default.
• W2054895688 countsByYear W20548956882020 @default.
• W2054895688 countsByYear W20548956882021 @default.
• W2054895688 countsByYear W20548956882022 @default.
• W2054895688 countsByYear W20548956882023 @default.
• W2054895688 crossrefType "journal-article" @default.
• W2054895688 hasAuthorship W2054895688A5015505251 @default.
• W2054895688 hasAuthorship W2054895688A5026263532 @default.
• W2054895688 hasAuthorship W2054895688A5060036184 @default.
• W2054895688 hasAuthorship W2054895688A5076087889 @default.
• W2054895688 hasAuthorship W2054895688A5077796440 @default.
• W2054895688 hasConcept C121608353 @default.
• W2054895688 hasConcept C126322002 @default.
• W2054895688 hasConcept C126838900 @default.
• W2054895688 hasConcept C126894567 @default.
• W2054895688 hasConcept C141071460 @default.
• W2054895688 hasConcept C146357865 @default.
• W2054895688 hasConcept C151730666 @default.
• W2054895688 hasConcept C2775908122 @default.
• W2054895688 hasConcept C2777416452 @default.
• W2054895688 hasConcept C2777546739 @default.
• W2054895688 hasConcept C2777744392 @default.
• W2054895688 hasConcept C2778220009 @default.
• W2054895688 hasConcept C2778357063 @default.
• W2054895688 hasConcept C2910158674 @default.
• W2054895688 hasConcept C2993195994 @default.
• W2054895688 hasConcept C509974204 @default.
• W2054895688 hasConcept C71924100 @default.
• W2054895688 hasConcept C86803240 @default.
• W2054895688 hasConceptScore W2054895688C121608353 @default.
• W2054895688 hasConceptScore W2054895688C126322002 @default.
• W2054895688 hasConceptScore W2054895688C126838900 @default.
• W2054895688 hasConceptScore W2054895688C126894567 @default.
• W2054895688 hasConceptScore W2054895688C141071460 @default.
• W2054895688 hasConceptScore W2054895688C146357865 @default.
• W2054895688 hasConceptScore W2054895688C151730666 @default.
• W2054895688 hasConceptScore W2054895688C2775908122 @default.
• W2054895688 hasConceptScore W2054895688C2777416452 @default.
• W2054895688 hasConceptScore W2054895688C2777546739 @default.
• W2054895688 hasConceptScore W2054895688C2777744392 @default.
• W2054895688 hasConceptScore W2054895688C2778220009 @default.
• W2054895688 hasConceptScore W2054895688C2778357063 @default.
• W2054895688 hasConceptScore W2054895688C2910158674 @default.
• W2054895688 hasConceptScore W2054895688C2993195994 @default.
• W2054895688 hasConceptScore W2054895688C509974204 @default.
• W2054895688 hasConceptScore W2054895688C71924100 @default.
• W2054895688 hasConceptScore W2054895688C86803240 @default.
• W2054895688 hasIssue "1" @default.
• W2054895688 hasLocation W20548956881 @default.
• W2054895688 hasLocation W20548956882 @default.
• W2054895688 hasOpenAccess W2054895688 @default.
• W2054895688 hasPrimaryLocation W20548956881 @default.

• next